Impact of Brain Connectome and Personality on Cognitive Rehabilitation in Multiple Sclerosis
1 other identifier
interventional
50
1 country
1
Brief Summary
This study aims to apply baseline MRI and neuropsychological measures to predict patient responses to behavioral cognitive rehabilitation. Training will take place over 12 weeks, 1 hour per day, 5 days per week. The investigator hypothesizes the following: \[1a\] The investigator expects that individuals with low baseline Conscientiousness will experience a lower magnitude of overall cognitive improvement following rehabilitation
- 1.b\] The investigator expects the impact of Conscientiousness on fidelity of rehabilitation will in part be moderated by individual differences in program adherence and executive function
- 2.a\] The investigator expects that individual differences in structural and functional connectome disturbances will in part explain differences in participant responses to cognitive rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable multiple-sclerosis
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2017
CompletedFirst Posted
Study publicly available on registry
October 11, 2017
CompletedStudy Start
First participant enrolled
November 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2018
CompletedNovember 26, 2018
November 1, 2018
6 months
September 27, 2017
November 21, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Impact of Conscientiousness on Cognitive Training Outcomes
The investigator expects baseline Conscientiousness to correlate positively with cognitive gains following rehabilitation. Conscientiousness will be measured using the NEO-Five Factor Inventory (NEOFFI). All scores for personality testing will be converted to age-corrected t-scores for final analysis. These are therefore standardized values without units.
This outcome will be measured according to changes from baseline cognition to follow-up measures, 12 weeks later (following cognitive rehabilitation)
Cognitive Training Outcomes
Cognitive gains will be measured according to differences between baseline and followup testing for the following tests of cognition. * Brief Visuospatial Memory Test (BVMT). This is a test of visual and spatial learning and memory. * California Verbal Learning Test (CVLT). This is a test of verbal learning and memory. * Symbol Digit Modalities Test (SDMT). This is a test of visual information processing speed. All scores for cognitive testing will be converted to age-corrected t-scores for final analysis. These are therefore standardized values without units.
This outcome will be measured according to changes from baseline cognition to follow-up measures, 12 weeks later (following cognitive rehabilitation)
Secondary Outcomes (3)
Moderating role of executive function
12 weeks, as above
Moderating role of program adherence
12 weeks, as above
Impact of baseline brain connectivity on cognitive rehabilitation outcomes
12 weeks, as above
Study Arms (1)
Cognitive Training
EXPERIMENTALIndividuals will take part in a computer-based cognitive training program. The program is aimed at building attention, processing speed, memory, and executive function.
Interventions
Individuals will take part in a computer-based cognitive training program. The program is aimed at building attention, processing speed, memory, and executive function.
Eligibility Criteria
You may qualify if:
- For all subjects:
- males and females above age 18
- fluent in English
- education \>9 years
- Clinically definite MS diagnosis
- Expanded Disability Status Scale (EDSS) ≤ 6.5
- MS patients must be relapse-free and stable from the time of their MRI acquired for the CEG-MS study
- Willing and able to comply with the study procedures for the duration of the trial
You may not qualify if:
- history of serious medical or psychiatric illness (other than MS in the patient group) that may affect cognitive functioning
- color-blindness
- history of developmental disability
- past or current alcohol or substance dependence
- History of major depressive disorder, bipolar disorder, or psychotic disorder predating the onset of MS
- History of traumatic brain injury as defined by trauma causing loss of consciousness or transient post-traumatic or retrograde amnesia exceeding 5 min
- Other pathology related to MRI abnormalities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jacobs Comprehensive Multiple Sclerosis Treatment and Research Center
Buffalo, New York, 14203, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 27, 2017
First Posted
October 11, 2017
Study Start
November 1, 2017
Primary Completion
April 30, 2018
Study Completion
October 20, 2018
Last Updated
November 26, 2018
Record last verified: 2018-11